Clinical trial
TAURAS - T790 AURA ScreenFailure SOC Registry Study
NCT02405247 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TAURAS - T790 AURA ScreenFailure SOC Registry Study
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Terminated
- Start date
- June 30, 2015
- Completion date
- July 31, 2015
- Enrollment
- 400 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
non small cell lung cancer